Piermont Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-10,870
| Closed | -$204K | – | 237 |
|
|
2018
Q1 | $204K | Sell |
10,870
-1,860
| -15% | -$34.9K | 0.07% | 232 |
|
|
2017
Q4 | $245K | Sell |
12,730
-760
| -6% | -$14.6K | 0.08% | 225 |
|
|
2017
Q3 | $241K | Sell |
13,490
-14,033
| -51% | -$251K | 0.08% | 232 |
|
|
2017
Q2 | $492K | Sell |
27,523
-5,160
| -16% | -$92.2K | 0.14% | 228 |
|
|
2017
Q1 | $474K | Buy |
32,683
+6,530
| +25% | +$94.7K | 0.11% | 235 |
|
|
2016
Q4 | $482K | Sell |
26,153
-510
| -2% | -$9.4K | 0.11% | 228 |
|
|
2016
Q3 | $506K | Buy |
+26,663
| New | +$506K | 0.12% | 235 |
|